Heidi Sami, MD
Rheumatology · Annapolis, MDNPI 1720305857
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,272 of the $7,722 with a category attached, or 68.3%. 27 manufacturers reported payments, led by Amgen at 42.8% of the total. Reporting peaked in 2019 at $4,308 and has fallen 74.5% since, to $1,100 in 2025.
Across 255 payments — averaging $30.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$3K
- AbbVie$845
- Johnson & Johnson$602
- Lilly USA, LLC$518
- UCB, Inc.$459
- Novartis$295
- plus $2K from 21 others
Across 2 payments — averaging $2625.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi US Services Inc.$5K
What the payments were for
- Consulting fees$1001%
- Speaking & faculty fees$2,25029%
- Travel & lodging$871%
- Food & beverage$5,27268%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 51 | $3,304 |
| AbbVie | 50 | $845 |
| Johnson & Johnson | 25 | $602 |
| Lilly USA, LLC | 22 | $518 |
| UCB, Inc. | 19 | $459 |
| Novartis | 14 | $295 |
| E.r. Squibb & Sons, L.L.C. | 16 | $295 |
| Mallinckrodt Enterprises LLC | 7 | $185 |
| Sobi, Inc | 3 | $157 |
| Bristol Myers Squibb | 9 | $122 |
| AstraZeneca(2 entities) | 5 | $118 |
| GSK | 5 | $108 |
| Radius Health, Inc. | 2 | $105 |
| Cardinal Health 110 LLC | 1 | $100 |
| Pfizer | 5 | $88 |
| ANI Pharmaceuticals, Inc. | 4 | $76 |
| Genentech USA, Inc. | 3 | $59 |
| Boehringer Ingelheim | 2 | $54 |
| Regeneron Healthcare Solutions, Inc. | 3 | $49 |
| Sandoz | 2 | $34 |
| Mallinckrodt Hospital Products Inc. | 1 | $31 |
| Boston Scientific | 1 | $28 |
| Mylan Institutional Inc. | 1 | $24 |
| Aurinia Pharma U.S., Inc. | 1 | $21 |
| Actelion Pharmaceuticals US, Inc. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Sanofi | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KRYSTEXXA$2,250
How this compares
$7,722 in reported general payments places this provider in the 70th percentile of 173 rheumatology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxychloroquine Sulfate | 57 | $2,563 |
| Leflunomide | 15 | $1,513 |
| MethotrexateMethotrexate Sodium | 31 | $1,247 |
| Prednisone | 12 | $114 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Annapolis
- Ashok JacobAnnapolis$32K
- Mariam AmeriAnnapolis$22K
- Susan BergerAnnapolis$12K
- Yiran JiangAnnapolis$7K
- Sonie UpretiAnnapolis$6K
- Evan SiegelRockville$594K
- Donald ThomasGreenbelt$471K
- Edmund MaclaughlinEaston$410K
- Michelle PetriBaltimore$381K
- Herbert BarafWheaton$268K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.